Letters, Testimony & Comments

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations...
June 19 2013
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
Hearing Testimony Scott Koenig, M.D., PH.D. Before the House of Representatives Committee on Small Business Good morning Chairman...
April 7 2011
Access to Early Capital In the United States and globally, commercial development of biotechnology relies on the continuing...
May 27 2010
The Biotechnology industry Organization appreciates the opportunity to respond to the Request for Information issued by the Office of...
May 25 2010
U.S. Department of State
June 1 2009
The Biotechnology Industry Organization (BIO) appreciates this opportunity tp provide the perspective of its members on the Bayh-Dole Act...
August 27 2007
Janna Tom, Assistant Director, Office of Technology Transfer, University of California; Vice President for Public Policy, Association of...
November 20 2004
Chairman Bilirakis and Members of the Committee, I am pleased to testify before you today regarding technology transfer issues as they...
July 10 2003
Summary The biotechnology industry is the most research and development intensive and capital-focused industry in the world. The United...
April 11 2002
Government's role in developing solutions for diseases that disproportionately affect developing countries Introduction: -...
National Institutes of Health: An International Perspective NIH Mission: To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT...
June 19 2013
The TTIP represents a profoundly important opportunity to advance progress in these areas. The following comments represent BIO’s initial suggestions for the formulation of negotiating objectives relevant to biotechnology.  
June 19 2013
We understand the challenges that India faces with respect to healthcare and the innovative biotechnology industry stands ready to work with India to help address them.  
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
April 7 2011
The House Subcommittee on Healthcare and Technology held a hearing on The Creating Jobs Through Small Business Innovation Act of 2011, a bill that would reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which help fund small innovative companies on the brink of new technologies and discoveries.
May 27 2010
The paper highlights factors that contribute to enabling environments for promising technologies to gain access to early capital.
June 6 2011
The United States Supreme Court issued it's opinion on the appeal of Stanford University against Roche Diagnostics, which is of significant importance because of its potential impact on university technology transfer, development and commercialization of university-generated basic technology and scientific collaborations between university and private-sector scientists.
April 7 2011
Today, the House Subcommittee on Healthcare and Technology will hold a hearing on The Creating Jobs Through Small Business Innovation Act of 2011, a bill that would reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which help fund small innovative companies on the brink of new technologies and discoveries.
July 30 2008
Small businesses that are majority-backed by venture capital, many of which are producing biotech therapies and cures, will be eligible for a portion of Small Business Innovation Research (SBIR) grants under a bill reported out of the Senate Committee on Small Business today. The bill reauthorizes the SBIR program for 14 years.
September 20 2006
The Milken Institute study released today entitled “Mind-to-Market: A Global Analysis of University Biotechnology Technology Transfer and Commercialization” reaffirms the critical role of technology transfer in the development of the biotechnology industry worldwide, said Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood.
May 30 2002
The Biotechnology Industry Organization’s (BIO) annual meeting, BIO 2002 in Toronto, will feature a Technology Transfer Forum that will bring science and business together to speed commercialization of basic technology into useful consumer products.